Download fulltext HTML
Rumyantsev, P. O., Trukhin, A. A., Degtyarev, M. V., Sheremeta, M. S., Nizhegorodova, K. S., Slashchuk, K. Y., Sirota, Y. I., Nikitaev, V. G., Pronichev, A. N., Dubov, L. Y., & Shtotsky, Y. V. (2018). Estimated Inpatient Hospital Stay in Individual Wards: Guidelines on Radiation Safety after Radioiodine Therapy. KnE Energy, 3(2), 428–432. https://doi.org/10.18502/ken.v3i2.1847

https://doi.org/10.18502/ken.v3i2.1847

statistics

  • 343 Abstract Views
  • 283 PDF Views
  • 0 HTML Views

authors

  • P O Rumyantsev
    No author data available.
  • A A Trukhin
    No author data available.
  • M V Degtyarev
    No author data available.
  • M S Sheremeta
    No author data available.
  • K S Nizhegorodova
    No author data available.
  • K Yu Slashchuk
    No author data available.
  • Ya I Sirota
    No author data available.
  • V G Nikitaev
    No author data available.
  • A N Pronichev
    No author data available.
  • L Yu Dubov
    No author data available.
  • Yu V Shtotsky
    No author data available.

Published Date

  • Apr 17, 2018

Estimated Inpatient Hospital Stay in Individual Wards: Guidelines on Radiation Safety after Radioiodine Therapy

KnE Energy / The 2nd International Symposium "Physics, Engineering and Technologies for Biomedicine" / Pages 428–432

Abstract

Radionuclide therapy safety requirements are regulated by the Russian Radiation Safety Standards (RRSS), which state the maximum allowed radionuclide activity in the body and the equivalent dose rate (EDR) of gamma radiation. Therefore, it is necessary to estimate the time of an inpatient hospital stay in specially designed radionuclide therapy wards. The article presents the findings of individual 131I biokinetics studies in 64 patients admitted to radioiodine therapy of thyrotoxicosis and differentiated thyroid cancer. We developed a method to calculate the time interval to reach the EDR of 20μSv/h and the recommended EDR of 3 and 0.3μSv/h for adults and children, respectively. It is based on the measurement of the 131I excretion constant.


Keywords: Radioiodine therapy, Radiation safety, Guideline

References
[1] F. A. Mettler Jr, M.J. Guiberteau. «Essentials of Nuclear Medicine Imaging 6th Edition», Elsevier Saunders, Page 116, 2012.


[2] P. O. Rumiantsev, A.A Trukhin, M.V. Degtyarev, «Personalized approach to thyrotoxicosis treatment: the history of dosimetric concepts development» Vestnik Rentgenologii i Radiologii, 98 (4), 2017.


[3] C. J. Lote, «Principles of renal physiology (4th edn)», Kluwer, 2000.


[4] T.S. Michael, A.R Suhail, «Transient Hypothyroidism after Radioiodine for Graves’ Disease: Challenges in Interpreting Thyroid Function Tests», Clinical Medicine & Research, 14(1), 40–45, 2016.


[5] IAEA Vienna, «Radiation protection in medicine», IAEA Library, 429 pages, 2015.


[6] Russian Federation Normatives and rules, «Radiation safety normatives and rules » 30, 1–70, 2009.


[7] P. O. Rumiantsev, M. S. Sheremeta, A. V. Kiyaev, L.A. Kurimshova, O.A. Chikulaeva. «Efficacy and safety of radioiodine treatment of Graves’ disease in children and adolescents», 17, 6–11, 2017.